Trials / Completed
CompletedNCT01191112
Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Abbott Nutrition · Industry
- Sex
- All
- Age
- 1 Year – 13 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the safe use and tolerance of a peptide-based formula in children with gastrointestinal dysfunction and/or feeding intolerance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Peptide based enteral formula | Sole source nutrition as per HCP |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2010-08-30
- Last updated
- 2015-03-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01191112. Inclusion in this directory is not an endorsement.